The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults

KN Patel, L Yip, CC Lubitz, EG Grubbs, BS Miller… - Annals of …, 2020 - journals.lww.com
Objective: To develop evidence-based recommendations for safe, effective, and appropriate
thyroidectomy. Background: Surgical management of thyroid disease has evolved …

Thyroid ultrasound and its ancillary techniques

J Bojunga, P Trimboli - Reviews in Endocrine and Metabolic Disorders, 2024 - Springer
Ultrasound (US) of the thyroid has been used as a diagnostic tool since the late 1960s. US is
the most important imaging tool for diagnosing thyroid disease. In the majority of cases a …

[HTML][HTML] Multimodal imaging of thyroid cancer

K Brauckhoff, M Biermann - Current Opinion in Endocrinology …, 2020 - journals.lww.com
The mainstay of diagnosing thyroid cancer is thyroid ultrasound with ultrasound-guided
FNB. Contrast-enhanced computed tomography and PET with [18 F]-fluorodeoxyglucose …

Time to separate persistent from recurrent differentiated thyroid cancer: different conditions with different outcomes

G Sapuppo, M Tavarelli, A Belfiore… - The Journal of …, 2019 - academic.oup.com
Context Differentiated thyroid cancer (DTC) has an excellent prognosis, but up to 20% of
patients with DTC have disease events after initial treatment, indistinctly defined as …

[HTML][HTML] Validation of CT-based risk stratification system for lymph node metastasis in patients with thyroid cancer

YH Roh, SR Chung, JH Baek, YJ Choi… - Korean Journal of …, 2023 - ncbi.nlm.nih.gov
Objective To evaluate the computed tomography (CT) features for diagnosing metastatic
cervical lymph nodes (LNs) in patients with differentiated thyroid cancer (DTC) and validate …

[HTML][HTML] Predictive factors of recurrence in patients with differentiated thyroid carcinoma: a retrospective analysis on 579 patients

F Medas, GL Canu, F Boi, ML Lai, E Erdas, PG Calò - Cancers, 2019 - mdpi.com
Differentiated thyroid carcinoma (DTC) is usually associated with a favorable prognosis.
Nevertheless, up to 30% of patients present a local or distant recurrence. The aim of this …

[HTML][HTML] Clinicopathological features as prognostic predictors of poor outcome in papillary thyroid carcinoma

AA Povoa, E Teixeira, MR Bella-Cueto, M Melo… - cancers, 2020 - mdpi.com
Simple Summary Thyroid cancer incidence is increasing, with overdiagnosis being the
major driver of the thyroid cancer “epidemic”. Papillary thyroid carcinoma, usually with …

The prospective implementation of the 2015 ATA guidelines and modified ATA recurrence risk stratification system for treatment of differentiated thyroid cancer in a …

J Wu, XY Hu, S Ghaznavi, S Kinnear, CJ Symonds… - Thyroid, 2022 - liebertpub.com
Objective: To present clinical outcomes of the prospective implementation of the 2015
American Thyroid Association (ATA) guidelines for the management of thyroid nodules and …

[HTML][HTML] miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1

J Han, M Zhang, C Nie, J Jia, F Wang, J Yu, W Bi… - Cell death & …, 2019 - nature.com
The incidence of papillary thyroid cancer (PTC) has been rapidly increasing in recent years.
PTC is prone to lymph node metastasization, which further increases the recurrence rate …

Mebendazole inhibits tumor growth and prevents lung metastasis in models of advanced thyroid cancer

T Williamson, TB Mendes, N Joe… - Endocrine-related …, 2020 - erc.bioscientifica.com
The most common thyroid malignancy is papillary thyroid cancer. While a majority respond
to therapy and have a favorable prognosis, some papillary thyroid cancers persist. This …